Whole lung lavage: Treating pulmonary alveolar proteinosis at the time of COVID pandemic

Respir Med Case Rep. 2022:39:101707. doi: 10.1016/j.rmcr.2022.101707. Epub 2022 Jul 14.

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare syndrome due to increased production or decreased clearance of surfactant in alveoli and terminal bronchi that cause hypoxemic respiratory insufficiency. Here we present a patient with PAP whose disease was exacerbated by superimposed COVID-19 pneumonia. He underwent whole lung lavage (WLL). Evaluation of the viral count of the first and the last lavage of the left lung showed viral load in the alveolar space dropped by approximately 10-folds, however the magnitude of the viral load was substantial in both lavage samples. Whole pulmonary lavage may be used as a treatment option on patients with PAP even when the disease is exacerbated by COVID-19 pneumonia.

Keywords: COVID-19; Pulmonary alveolar proteinosis; Viral load; Whole pulmonary lavage.

Publication types

  • Case Reports